Sabra Health Care’s Q2 normalized AFFO beats prior metrics, though the company reports a net loss of $0.10 per share.
Sabra Health Care reported Q2 normalized adjusted funds from operations (AFFO) of $0.40 per diluted common share, aligning with its reiterated guidance. The company posted a net loss of $0.10 per share, while funds from operations (FFO) stood at a negative $0.02.
Normalized FFO for the quarter was $0.38, with AFFO at $0.39. The results reflect ongoing operational performance amid broader sector challenges. Comparable figures for prior periods were not disclosed in the release.
The company reiterated its full-year outlook, signaling confidence in sustained performance despite the quarterly loss.